20% Albumin

Class Colloid fluid
Chemistry

Concentrated human protein solution

Routes of administration

IV

Absorption

Zero oral bioavailability; degraded into component peptides by digestive enzymes

Solubility

pKa 6.75; good water solubility

Distribution

VOD = 0.07L/kg (effectively confined to the circulating volume); minimally protein bound

Metabolism

Metabolised mainly by the reticuloendothelial system

Elimination

Minimal renal excretion, except in cases of protein-losing nephropathy. Most of it is degraded by macrophages; 10% is eliminated though the gut

Time course of action

Half life of around 27 days

Target receptor

Various molecules in the bloodstream bind and form complexes

Mechanism of action

Multiple roles, including oncotic, immunomodulatory and transport roles. Acts as a binding substrate for xenobiotics.
Volume expansion:
- After 25-30 minutes the oncotic pressure attracts a further 250ml of fluid into the intravascular space (in theory; in practice it may only be a further 50-100ml)
- This may still be below the circulatory reflex activation threshold
Change in osmolality:
- minimal; unnoticed by osmoreceptors (100ml of hypotonic saline carrier fluid is too small a volume)
Change in biochemistry:
- trivial sodium drop
- trivial chloride elevation

Clinical effects
Increased circulating volume; may cause circulaotry overload; small risk of anaphylaxis or allergica reaction; may change the free fraction of highly protein-bound drugs
Literature reference
CSL Behring product sheet
CICM details of understanding Level 1
Mentioned around Deranged Physiology
Related SAQs

Question 9 from the first paper of 2022

Question 12 from the second paper of 2020

Question 1 from the second paper of 2015

Question 1(p.2) from the second paper of 2009